Breast cancer
1,076 results
101 - 200
Two thirds of reduction in breast cancer mortality due to therapy advances
Axillary treatment for operable primary breast cancer - Extended duration of letrozole for ER+ breast cancer reduces recurrence but not mortality
- Cyclin-dependent kinase inhibitor for advanced breast cancer
Risk‐reducing mastectomy for unaffected women with a strong family history of breast cancer- Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
- Taxanes for adjuvant treatment of early breast cancer
- Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery
- The effects of physical exercise in women in treatment for or survivors of breast cancer
- Aromatase inhibitors vs. tamoxifen in postmenopausal women with early breast cancer
- Follow‐up strategies for women treated for early breast cancer
- Combination versus sequential single agent chemotherapy for metastatic breast cancer
- Antitumour antibiotic containing regimens for metastatic breast cancer
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
- PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
- Sequencing of chemotherapy and radiotherapy for early breast cancer: Cochrane systematic review
- Small increase in risk for breast cancer associated with levonorgestrel-releasing intrauterine device
- Yoga + meditation decreases short-term menopausal suffering in breast cancer survivors
- Acupuncture may reduce aromatase inhibitor–related arthralgia in women with breast cancer
- Taxane-containing regimens for metastatic breast cancer: Cochrane systematic review
- Aspirin does not reduce the risk of recurrence or improve survival in adults with breast cancer
- Having a primary care doc is assoc with better outcomes in women with breast cancer
- Multi-agent chemotherapy for early breast cancer: Cochrane systematic review
- Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- PARP (poly ADP‐ribose polymerase) inhibitors for locally advanced or metastatic breast cancer
- Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple‐negative breast cancer
- Bisphosphonates and other bone agents for breast cancer: Cochrane systematic review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer
- Anastrozole decreases rate of breast cancer in high-risk postmenopausal women (IBIS-II)
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Screening for breast cancer: False-positive rates 60% over 10 years
- Shared decision‐making for supporting women’s decisions about breast cancer screening
- Sentinel lymph node biopsy in early-stage breast cancer
- Non-hormonal interventions for hot flushes in women with a history of breast cancer: Cochrane systematic review
- Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with breast cancer
- Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer
- 10 years of tamoxifen better than 5 in women with ER+ breast cancer (ATLAS)
- Online support groups for women with breast cancer: Cochrane systematic review
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Platinum‐based chemotherapy for early triple‐negative breast cancer
- Nipple- and areola-sparing mastectomy for the treatment of breast cancer: Cochrane systematic review
- Upper-body weight lifting does not increase women's risk of breast cancer-related lymphedema
- Home-based multidimensional survivorship programmes for breast cancer survivors: Cochrane systematic review
- Tibetan yoga modestly improves fatigue and sleep quality in women with breast cancer undergoing chemotherapy
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment: Cochrane systematic review
- Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
- Non-hormonal interventions for hot flushes in women with a history of breast cancer
- Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer
- Even before the new guidelines, a majority of women stated a preference for breast cancer screening in their 40s
- Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery
- Women with ER+/HER-/node- breast cancer and intermediate Oncotype score do not benefit from chemo (TAILORx)
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- USPSTF 2019 recommends offering risk-reducing medication to women at increased risk of breast cancer (B recommendation)
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
- Extended follow-up: anastrozole better than placebo to prevent breast cancer in high-risk women (IBIS-II)
- Axillary treatment for operable primary breast cancer: Cochrane systematic review
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- Manual lymphatic drainage for lymphedema following breast cancer treatment: Cochrane systematic review
- 20-year follow-up of WHI trials: lower breast cancer mortality with CEE alone, no difference with CEE plus progesterone
- Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review
- Regional analgesia techniques for postoperative pain after breast cancer surgery: a network meta‐analysis
- Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients: Cochrane systematic review
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
- Bone‐modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta‐analysis
- Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy: Cochrane systematic review
- Breast cancer
- Breast surgery for metastatic breast cancer
- Genetic susceptibility to breast cancer
- Screening for breast cancer with mammography
- Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
- Partial breast irradiation versus whole breast radiotherapy for early breast cancer
- Bisphosphonates in breast cancer
- Breast cancer and hormonal contraceptives
- Self examination for breast cancer